This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsBiome Grow (BIO) 주식 개요는 대마초 사업에 중점을 두고 있습니다. 자세히 보기BIO 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6강점지난 5년 동안 수입이 매년 4.3% 증가했습니다.위험 분석의미 있는 시가총액이 없습니다(CA$562K)수익이 USD$1m 미만입니다(CA$0)마이너스 주주 지분주식은 유동성이 매우 낮습니다+ 위험 1건 추가모든 위험 점검 보기BIO Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCA$Current PriceCA$0.005해당 없음내재 할인율Est. Revenue$PastFuture-12m6m2016201920222025202620282031Revenue CA$0.3Earnings CA$0.04AdvancedSet Fair ValueView all narrativesBiome Grow Inc. 경쟁사Captor CapitalSymbol: CNSX:CPTRMarket cap: CA$767.1kLophos HoldingsSymbol: CNSX:MESCMarket cap: CA$858.6kSteep HillSymbol: CNSX:STPHMarket cap: CA$889.2kLowell FarmsSymbol: CNSX:LOWLMarket cap: CA$272.2k가격 이력 및 성과Biome Grow 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$0.00552주 최고가CA$0.0152주 최저가CA$0.005베타-0.0951개월 변동0%3개월 변동0%1년 변동-50.00%3년 변동-92.86%5년 변동-98.81%IPO 이후 변동-99.74%최근 뉴스 및 업데이트Board Change • Apr 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Feb 26Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Feb 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Dec 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Nov 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.더 많은 업데이트 보기Recent updatesBoard Change • Apr 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Feb 26Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Feb 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Dec 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Nov 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Oct 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Aug 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Jul 07Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Jul 08Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.분석 기사 • May 07Auditors Have Doubts About Biome Grow (CSE:BIO)Unfortunately for shareholders, when Biome Grow Inc. ( CSE:BIO ) reported results for the period to December 2020, its...분석 기사 • Mar 18Does Biome Grow (CSE:BIO) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Dec 03Does Biome Grow (CSE:BIO) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...공시 • Aug 06MYM Nutraceuticals Inc. (CNSX:MYM) completed the acquisition of Highland Grow Inc. from Biome Grow Inc. (CNSX:BIO).MYM Nutraceuticals Inc. (CNSX:MYM) entered into an agreement to acquire Highland Grow Inc. from Biome Grow Inc. (CNSX:BIO) for CAD 12.9 million on July 27, 2020. The total consideration consists of CAD 1.5 million in cash, 42.813 million common shares in the capital of MYM, representing 19% of MYM’s total issued and outstanding share capital (post closing) and 132.55 million newly-created non-voting class A special shares of MYM, which non-voting shares may be exchanged for shares of MYM in accordance with the class A special shares’ rights and restrictions. MYM has also agreed to loan Biome an amount equal to CAD 1 million for a term of 18 months. As security for the loan, 38.5 million consideration shares will be placed into escrow and released to Biome on regular intervals. Any proceeds received by Biome from the sale of such consideration shares shall be used to repay the loan until such time as the loan is discharged in full. As part of the transaction, Biome will become the largest shareholder of MYM. To finance the acquisition MYM has entered into a loan facility with 1909203 Ontario Inc. whereby MYM will borrow CAD 3 million. Upon completion of the transaction, Michael Wiener will resign as a director of Biome and will be appointed as Chief Executive Officer and a director of MYM. Robin Linden will resume his role as a Director and Chief Marketing Officer of MYM. Robert Wolf will also be appointed a Director of MYM. The cash proceeds of the transaction and the loan will principally be used by Biome to satisfy outstanding obligations owing to its senior lender. MYM Nutraceuticals Inc. (CNSX:MYM) completed the acquisition of Highland Grow Inc. from Biome Grow Inc. (CNSX:BIO) on August 4, 2020.주주 수익률BIOCA PharmaceuticalsCA 시장7D0%1.0%1.8%1Y-50.0%68.6%33.9%전체 주주 수익률 보기수익률 대 산업: BIO은 지난 1년 동안 68.6%의 수익을 기록한 Canadian Pharmaceuticals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: BIO은 지난 1년 동안 33.9%를 기록한 Canadian 시장보다 저조한 성과를 냈습니다.주가 변동성Is BIO's price volatile compared to industry and market?BIO volatilityBIO Average Weekly Movementn/aPharmaceuticals Industry Average Movement11.1%Market Average Movement10.0%10% most volatile stocks in CA Market17.8%10% least volatile stocks in CA Market3.9%안정적인 주가: BIO의 주가는 지난 3개월 동안 Canadian 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine BIO의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트n/an/aKhurram Malikwww.biomegrow.com는 대마초 사업에 중점을 두고 있습니다. 는 캐나다 토론토에 본사를 두고 있습니다.더 보기Biome Grow Inc. 기초 지표 요약Biome Grow의 순이익과 매출은 시가총액과 어떻게 비교됩니까?BIO 기초 통계시가총액CA$562.09k순이익 (TTM)-CA$2.13m매출 (TTM)n/a0.0x주가매출비율(P/S)-0.3x주가수익비율(P/E)BIO는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표BIO 손익계산서 (TTM)매출CA$0매출원가CA$0총이익CA$0기타 비용CA$2.13m순이익-CA$2.13m최근 보고된 실적Sep 30, 2023다음 실적 발표일해당 없음주당순이익(EPS)-0.019총이익률0.00%순이익률0.00%부채/자본 비율-86.7%BIO의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/08/04 22:42종가2024/05/07 00:00수익2023/09/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Biome Grow Inc.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Siddharth RajeevFundamental Research Corp.
Board Change • Apr 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Feb 26Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Feb 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Dec 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Nov 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Apr 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 19Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Feb 26Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Feb 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Dec 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Nov 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Oct 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Aug 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Jul 07Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Jul 08Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director John Lievonen was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
분석 기사 • May 07Auditors Have Doubts About Biome Grow (CSE:BIO)Unfortunately for shareholders, when Biome Grow Inc. ( CSE:BIO ) reported results for the period to December 2020, its...
분석 기사 • Mar 18Does Biome Grow (CSE:BIO) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 • Dec 03Does Biome Grow (CSE:BIO) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
공시 • Aug 06MYM Nutraceuticals Inc. (CNSX:MYM) completed the acquisition of Highland Grow Inc. from Biome Grow Inc. (CNSX:BIO).MYM Nutraceuticals Inc. (CNSX:MYM) entered into an agreement to acquire Highland Grow Inc. from Biome Grow Inc. (CNSX:BIO) for CAD 12.9 million on July 27, 2020. The total consideration consists of CAD 1.5 million in cash, 42.813 million common shares in the capital of MYM, representing 19% of MYM’s total issued and outstanding share capital (post closing) and 132.55 million newly-created non-voting class A special shares of MYM, which non-voting shares may be exchanged for shares of MYM in accordance with the class A special shares’ rights and restrictions. MYM has also agreed to loan Biome an amount equal to CAD 1 million for a term of 18 months. As security for the loan, 38.5 million consideration shares will be placed into escrow and released to Biome on regular intervals. Any proceeds received by Biome from the sale of such consideration shares shall be used to repay the loan until such time as the loan is discharged in full. As part of the transaction, Biome will become the largest shareholder of MYM. To finance the acquisition MYM has entered into a loan facility with 1909203 Ontario Inc. whereby MYM will borrow CAD 3 million. Upon completion of the transaction, Michael Wiener will resign as a director of Biome and will be appointed as Chief Executive Officer and a director of MYM. Robin Linden will resume his role as a Director and Chief Marketing Officer of MYM. Robert Wolf will also be appointed a Director of MYM. The cash proceeds of the transaction and the loan will principally be used by Biome to satisfy outstanding obligations owing to its senior lender. MYM Nutraceuticals Inc. (CNSX:MYM) completed the acquisition of Highland Grow Inc. from Biome Grow Inc. (CNSX:BIO) on August 4, 2020.
